|
|
 |
Recommended Results |
| |
|
|
| 公司介紹 |
| |
The company’s primary research directions include ribose antineoplastics and carbapenem antibiotics. The company has been successful in customizing Meropenem (cas :96036-03-2), Imipenem (cas :64221-86-9) , tebipenem (cas :161715-24-8), Decitabine (cas :2353-33-5), Gemcitabine (cas :95058-81-4), Capecitabine (cas :158798-73-3), Docetaxel (cas: 114977 -28-5), Ubenimex (cas :58970-76-6) and other types of side chains, intermediates, and also in synthesizing bulk drug research samples for domestic and foreign pharmaceutical companies |
| 相關產品 |
| |
pregabalin, ubenimex, capecitabine, doranidazole, bivalirudin, bendamustine, aprepitant, anidulafungin, imatinib , cabazitaxel, palonosetron, roflumilast, sarpogrelate |
| 公司基本資料 |
|
| 公司名稱: |
HK SIHUI PHARMACY LIITED |
| 連絡: |
聯絡我們
|
| 網址: |
********
|
| 電話: |
86-755-25152656 |
| 傳真: |
|
| 國家: |
中國 |
| 住址: |
Fengze 12K,Fenghu Building,Buji Rd.,Luohu Dist |
|
| 產品櫥窗 |
|
|
|
|
|
